title: Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
abstract: A patient developed pure red cell aplasia after ABO incompatible BMT for leukemia. He did not respond to plasma exchange. Antilymphocyte globulin therapy was followed by complete and permanent erythroid recovery with disappearance of recipient-derived isoagglutinins.
authors: Department of Internal Medicine, School of Medicine, University of Zagreb, Croatia.
authors: B
authors: B
authors: Labar
authors: V
authors: V
authors: Bogdanić
authors: D
authors: D
authors: Nemet
authors: J
authors: J
authors: Kovacević-Metelko
authors: M
authors: M
authors: Mrsić
authors: Z
authors: Z
authors: Pavletić
authors: S
authors: S
authors: Zupancić-Salek
authors: I
authors: I
authors: Radman
authors: I
authors: I
authors: Aurer
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001787:Blood Group Incompatibility / Q000209:etiology*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000601:surgery*; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000017:ABO Blood-Group System; D000961:Antilymphocyte Serum